Micellar nano-carriers for the delivery of STAT3 dimerization inhibitors to melanoma

The objective of this research was to develop polymeric micellar formulations of inhibitors of signal transducer and activator of transcription 3 (STAT3) dimerization, i.e., S3I-1757 and S3I-201, and evaluate the activity of successful formulations in B16-F10 melanoma, a STAT3 hyperactive cancer mod...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug delivery and translational research 2017-08, Vol.7 (4), p.571-581
Hauptverfasser: Soleimani, Amir H., Garg, Shyam M., Paiva, Igor M., Vakili, Mohammad R., Alshareef, Abdulraheem, Huang, Yung-Hsing, Molavi, Ommoleila, Lai, Raymond, Lavasanifar, Afsaneh
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The objective of this research was to develop polymeric micellar formulations of inhibitors of signal transducer and activator of transcription 3 (STAT3) dimerization, i.e., S3I-1757 and S3I-201, and evaluate the activity of successful formulations in B16-F10 melanoma, a STAT3 hyperactive cancer model, in vitro and in vivo. STAT3 inhibitory agents were encapsulated in methoxy poly(ethylene oxide)- b -poly(ε-caprolactone) (PEO 114 - b -PCL 22 ) and methoxy poly(ethylene oxide)- b -poly(α-benzyl carboxylate-ε-caprolactone) (PEO 114 - b -PBCL 20 ) micelles using co-solvent evaporation. Polymeric micelles of S3I-1757 showed high encapsulation efficiency (>88%), slow release profile (
ISSN:2190-393X
2190-3948
DOI:10.1007/s13346-017-0369-4